Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001209191-22-033933

SVP, GC and Corporate Affairs acquired 1,833 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kwon SoYoung SVP, GC and Corporate Affairs 2022-06-01 Option exercise +1,833 1,833 D
Derivatives
Kwon SoYoung SVP, GC and Corporate Affairs 2022-06-01 Option exercise · Restricted Stock Unit −1,833 3,667 D
Loading xslF345X03/doc4.xml…